Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Jan 24, 2022 9:32pm
146 Views
Post# 34356348

RE:RE:RE:RE:RE:RE:Aristotle Appointments

RE:RE:RE:RE:RE:RE:Aristotle AppointmentsSo lets get this straight.

1. $30M in revenue quote by ceo - outcome = $200K and Im being generous
2. $20M contract with Oncore = 2 years later Oncore folds not making a dime
3. Oncore signs $62M contract with iBodyCheck = 2 years later nothing and no proof the company even exists.
4. "large heath care provider" mentioned countless times = 0 results
5. fightfighers = 0 results
6. 1,000 covid tests per day "capacity" = calculated max result of 500 tests per day in most profitable quarter
7. Ramping up to 3,000 covids test per day = why was this said when not even remotely required by lack of demand.
8. Aristotle "released" April 1 - results = one heck of an april fools = combine cancer testing with covid so shareholders wont see there were 0 aristotle tests up until Q4 (maybe as we havent got those results plus they wont be split out anyway)
9. Q3 covid testing to return to Q1 levels.  Even with "including" cancer tests they didnt come anywhere close to that.
10. No mention of having to have CARE to sell tests and that doctors just cant request aristotle as its a cancer test and not a covid test.  How many years and this never mentioned once.


So after all that we are to believe anything has changed?  Why because they hired a few people and are spending 10 times the money they used to?

Newsflash they couldnt make money before covid.
Covid happend and it saved them.
They knew they couldnt make money so they spent money to buy CARE thinking maybe that will make them money.
They hired a couple people and sold a few tests.
They will now continue to spend money like no tomorrow thinking that if they just spend enough something will stick.  They dont care if they have to float more shares, do more reverse splits, all they have to do is spend more money.

All these "appointments" are free and you all have no clue if or how many of these appointments result in a aristotle test so stop trying to convice the sheep that will listen to you just like you did before with the insane $4B soon to be company worth that was being peddled on this board right before the whole thing went up in smoke.



<< Previous
Bullboard Posts
Next >>